- Lysophosphatidic acid: an ovarian cancer marker +12008 | Faculty of Medicine in Hradec Králové
- Lysophosphatidic acid: an ovarian cancer marker2008 | First Faculty of Medicine
- Current clinical utility of prostate cancer markers2019 | Second Faculty of Medicine
- GCPII and its close homolog GCPIII: From a neuropeptidase to a cancer marker and beyond2019 | Faculty of Science, Faculty of Physical Education and Sport
- miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?2015 | First Faculty of Medicine, Third Faculty of Medicine
- The importance of tumor markers and markers of angiogenesis for colorectal cancer prognosisPublication without faculty affiliation
- HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets2016 | First Faculty of Medicine
- Metallothioneins and Cancer2009 | Second Faculty of Medicine
- 37th Immunoanalytical days, 10.-12.4.2016, Pilsen, Czech RepublicPublication without faculty affiliation
- Benefit of determining [-2]proPSA levels in the differential diagnosis of prostate cancer2014 | Faculty of Medicine in Pilsen
- Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction2012 | Faculty of Science, Second Faculty of Medicine
- Study of Metallothionein Role in Spinocellular Carcinoma Tissues of Head and Neck Tumours using Brdicka Reaction2012 | Second Faculty of Medicine
- Overexpression of CD44v8-10 in Colon Polyps-A Possible Key to Early Diagnosis2021 | Faculty of Medicine in Hradec Králové
- Selective recognition of a saccharide-type tumor marker with natural and synthetic ligands: a new trend in cancer diagnosis2010 | First Faculty of Medicine
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report2010 | Central Library of Charles University
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report2010 | Faculty of Medicine in Pilsen
- Lysophosphatidic acid in ovarian carcinoma patients +12006 | Faculty of Medicine in Hradec Králové
- Determination of Anti-Cathepsin-D Antibodies in Human Blood Sera of Oncological Patients2012 | First Faculty of Medicine
- Lysophosphatidic acid in ovarian carcinoma patients2006 | First Faculty of Medicine
- Design of Highly Potent Urea-Based, Exosite-Binding Inhibitors Selective for Glutamate Carboxypeptidase II2015 | Faculty of Science
- Modern bioanalysis of proteins by electrophoretic techniques2014 | Second Faculty of Medicine
- Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery2014 | Faculty of Science
- DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening2017 | Faculty of Science
- Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer2016 | Second Faculty of Medicine, First Faculty of Medicine
- Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers2012 | Second Faculty of Medicine
- Expression of glutamate carboxypeptidase II in human brain2007 | Second Faculty of Medicine
- Human PROMININ-1 (CD133) Is Detected in Both Neoplastic and Non-Neoplastic Salivary Gland Diseases and Released into Saliva in a Ubiquitinated Form2014 | Faculty of Medicine in Hradec Králové
- Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer2020 | Central Library of Charles University, First Faculty of Medicine